382 related articles for article (PubMed ID: 21935895)
1. Overview of receptor allosterism.
Gregory KJ; Sexton PM; Christopoulos A
Curr Protoc Pharmacol; 2010 Dec; Chapter 1():Unit 1.21. PubMed ID: 21935895
[TBL] [Abstract][Full Text] [Related]
2. G protein-coupled receptor allosterism and complexing.
Christopoulos A; Kenakin T
Pharmacol Rev; 2002 Jun; 54(2):323-74. PubMed ID: 12037145
[TBL] [Abstract][Full Text] [Related]
3. When simple agonism is not enough: emerging modalities of GPCR ligands.
Smith NJ; Bennett KA; Milligan G
Mol Cell Endocrinol; 2011 Jan; 331(2):241-7. PubMed ID: 20654693
[TBL] [Abstract][Full Text] [Related]
4. Strategies for the identification of allosteric modulators of G-protein-coupled receptors.
Burford NT; Watson J; Bertekap R; Alt A
Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747
[TBL] [Abstract][Full Text] [Related]
5. Allosteric modulation of G protein-coupled receptors.
May LT; Leach K; Sexton PM; Christopoulos A
Annu Rev Pharmacol Toxicol; 2007; 47():1-51. PubMed ID: 17009927
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the novel positive allosteric modulator, LY2119620, at the muscarinic M(2) and M(4) receptors.
Croy CH; Schober DA; Xiao H; Quets A; Christopoulos A; Felder CC
Mol Pharmacol; 2014 Jul; 86(1):106-15. PubMed ID: 24807965
[TBL] [Abstract][Full Text] [Related]
7. Bitopic Ligands and Metastable Binding Sites: Opportunities for G Protein-Coupled Receptor (GPCR) Medicinal Chemistry.
Fronik P; Gaiser BI; Sejer Pedersen D
J Med Chem; 2017 May; 60(10):4126-4134. PubMed ID: 28140580
[TBL] [Abstract][Full Text] [Related]
8. Refining efficacy: allosterism and bias in G protein-coupled receptor signaling.
Luttrell LM; Kenakin TP
Methods Mol Biol; 2011; 756():3-35. PubMed ID: 21870218
[TBL] [Abstract][Full Text] [Related]
9. Orthosteric/allosteric bitopic ligands: going hybrid at GPCRs.
Valant C; Sexton PM; Christopoulos A
Mol Interv; 2009 Jun; 9(3):125-35. PubMed ID: 19592673
[TBL] [Abstract][Full Text] [Related]
10. A simple method to detect allostery in GPCR dimers.
Goupil E; Laporte SA; Hébert TE
Methods Cell Biol; 2013; 117():165-79. PubMed ID: 24143977
[TBL] [Abstract][Full Text] [Related]
11. Drugs for allosteric sites on receptors.
Wenthur CJ; Gentry PR; Mathews TP; Lindsley CW
Annu Rev Pharmacol Toxicol; 2014; 54():165-84. PubMed ID: 24111540
[TBL] [Abstract][Full Text] [Related]
12. Molecular alliance-from orthosteric and allosteric ligands to dualsteric/bitopic agonists at G protein coupled receptors.
Mohr K; Schmitz J; Schrage R; Tränkle C; Holzgrabe U
Angew Chem Int Ed Engl; 2013 Jan; 52(2):508-16. PubMed ID: 23225228
[TBL] [Abstract][Full Text] [Related]
13. G-protein-coupled receptor allosterism: the promise and the problem(s).
Christopoulos A; May LT; Avlani VA; Sexton PM
Biochem Soc Trans; 2004 Nov; 32(Pt 5):873-7. PubMed ID: 15494038
[TBL] [Abstract][Full Text] [Related]
14. Recent Advances in the Drug Discovery and Development of Dualsteric/ Bitopic Activators of G Protein-Coupled Receptors.
Reinecke BA; Wang H; Zhang Y
Curr Top Med Chem; 2019; 19(26):2378-2392. PubMed ID: 31833462
[TBL] [Abstract][Full Text] [Related]
15. Allosteric ligands for G protein-coupled receptors: a novel strategy with attractive therapeutic opportunities.
De Amici M; Dallanoce C; Holzgrabe U; Tränkle C; Mohr K
Med Res Rev; 2010 May; 30(3):463-549. PubMed ID: 19557759
[TBL] [Abstract][Full Text] [Related]
16. Allosteric properties of G protein-coupled receptor oligomers.
Springael JY; Urizar E; Costagliola S; Vassart G; Parmentier M
Pharmacol Ther; 2007 Sep; 115(3):410-8. PubMed ID: 17655934
[TBL] [Abstract][Full Text] [Related]
17. Allosteric modulation of G protein-coupled receptors: a pharmacological perspective.
Keov P; Sexton PM; Christopoulos A
Neuropharmacology; 2011 Jan; 60(1):24-35. PubMed ID: 20637785
[TBL] [Abstract][Full Text] [Related]
18. Allosteric modulators of rhodopsin-like G protein-coupled receptors: opportunities in drug development.
Müller CE; Schiedel AC; Baqi Y
Pharmacol Ther; 2012 Sep; 135(3):292-315. PubMed ID: 22728155
[TBL] [Abstract][Full Text] [Related]
19. Orthosteric- and allosteric-induced ligand-directed trafficking at GPCRs.
Digby GJ; Conn PJ; Lindsley CW
Curr Opin Drug Discov Devel; 2010 Sep; 13(5):587-94. PubMed ID: 20812150
[TBL] [Abstract][Full Text] [Related]
20. Interactions of orthosteric and allosteric ligands with [3H]dimethyl-W84 at the common allosteric site of muscarinic M2 receptors.
Tränkle C; Weyand O; Voigtländer U; Mynett A; Lazareno S; Birdsall NJ; Mohr K
Mol Pharmacol; 2003 Jul; 64(1):180-90. PubMed ID: 12815174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
